by Vora Corporate Finance | Aug 19, 2025 | Insights, Private Equity & IPO
Transaction: SRV Hospitals, a Mumbai-based multi-specialty hospital chain, has raised INR 140 crores in funding from InvAscent, a leading private equity fund focused on the life sciences sector. The funding will support SRV’s growth strategy, centered on its...
by Vora Corporate Finance | Aug 19, 2025 | Insights
There were no main board IPOs in March and April 2025. There were 05 SME IPOs in April 2025 as against 07 SME IPOs in March 2025. India’s IPO market began 2025 on a subdued note, with only 10 mainboard listings as companies held back amid market volatility, global...
by Vora Corporate Finance | Aug 19, 2025 | Insights
The BSE Sensex closed at 80,242 up by 4% and the Nifty 50 closed at 24,334 up by 3% in April 2025 amid sustained foreign fund inflows and robust corporate earnings. The market was buoyed by optimism the potential India-US trade deal and record high GST collection in...
by Vora Corporate Finance | Aug 19, 2025 | Insights
The US-China trade war has entered a new and precarious phase. What began as a series of tariffs and retaliatory measures has escalated into a systemic confrontation reshaping global trade dynamics. In early April 2025, President Trump imposed sweeping tariffs of up...
by Vora Corporate Finance | Apr 16, 2025 | Insights, Private Equity & IPO
Transaction: DCDC Kidney Care, which operates dialysis centers under the DCDC Kidney Care brand, has secured an investment of ₹150 crore from Singapore-based ABC Impact, the Asia-focused impact investor backed by Temasek. About DCDC Kidney Care: Founded in 2009, DCDC...
